Jeffrey Sunman
About Jeffrey Sunman
Jeff Smith is the Chief Research Officer at Precision BioSciences and a pivotal figure in the field of gene editing, holding over 75 patents related to genome editing tools.
Jeff Smith, Chief Research Officer at Precision BioSciences
Jeff Smith serves as the Chief Research Officer at Precision BioSciences. In this role, he oversees research and development activities, ensuring that the company's scientific endeavors align with its strategic goals. As a co-founder, he has played a pivotal role in shaping the company's direction and advancing its core technologies. His leadership has been integral to pioneering efforts in genome editing.
Jeff Smith Education and Expertise
Jeff Smith holds a Ph.D. from Duke University, which has been foundational in his extensive career in gene editing research and development. With over 17 years of experience in the field, his expertise encompasses advanced genome editing techniques and molecular biology. This academic background has equipped him with the skills necessary to lead innovative research initiatives at Precision BioSciences.
Jeff Smith Co-founder of Precision BioSciences
Jeff Smith co-founded Precision BioSciences, a company dedicated to advancing genome editing technologies. Through his efforts, the company has made significant strides in developing groundbreaking tools such as the ARCUS genome editing platform. His role as a co-founder underscores his commitment to translating scientific discoveries into practical applications.
Jeff Smith and the ARCUS Genome Editing Platform
Jeff Smith was instrumental in the discovery that led to the development of the ARCUS genome editing platform. This innovative technology has become a cornerstone of Precision BioSciences’ work, enabling precise and efficient modifications of genetic material. His contributions to this platform highlight his role in advancing the frontiers of genetic research.
Jeff Smith's Patents in Genome Editing
Jeff Smith is listed as an inventor on more than 75 foundational, issued patents related to the production and use of genome editing tools. These patents reflect his significant contributions to the field and his ability to develop technologies with practical applications in scientific research and medicine. His extensive patent portfolio underscores his influence and innovation in the realm of gene editing.